Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms Yasuhiko EbinaHidetaka KatabuchiHiroyuki Yoshikawa Special Article 26 April 2016 Pages: 419 - 434
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer Shinichi KomiyamaHidetaka KatabuchiHiroyuki Yoshikawa Special Article 03 May 2016 Pages: 435 - 446
PD-1/PD-L1 blockage in cancer treatment—from basic research to clinical application Masaki Mandai Introduction to Invited Review Articles 11 March 2016 Pages: 447 - 447
Basics of PD-1 in self-tolerance, infection, and cancer immunity Shunsuke Chikuma Invited Review Article 10 February 2016 Pages: 448 - 455
Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application Masaki MandaiJunzo HamanishiIkuo Konishi Invited Review Article 11 March 2016 Pages: 456 - 461
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues Junzo HamanishiMasaki MandaiIkuo Konishi Invited Review Article Open access 22 February 2016 Pages: 462 - 473
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute Yukiko MoriSatoshi NagayamaYoshiharu Sakai Original Article Open access 27 October 2015 Pages: 474 - 482
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin Katsunobu OyamaSachio FushidaTetsuo Ohta Original Article Open access 27 October 2015 Pages: 483 - 490
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin Hideaki YahataHiroaki KobayashiKiyoko Kato Original Article 10 December 2015 Pages: 491 - 497
Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy Futoshi IiokaKiyotaka IzumiHitoshi Ohno Original Article 13 October 2015 Pages: 498 - 505
Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan Yasushi IshidaDongmei QiuTatsuo Kuroda Original Article 30 November 2015 Pages: 506 - 516
Health insurance status and survival among patients with head and neck cancer in Japan Yukinori TakenakaToshimichi YasuiAtsuhiko Uno Original Article 07 November 2015 Pages: 517 - 522
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial) Seiki HasegawaMorihito OkadaTakashi Nakano Original Article Open access 17 November 2015 Pages: 523 - 530
Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations Yusuke OkumaYukio HosomiTsunekazu Hishima Original Article 08 December 2015 Pages: 531 - 538
Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients Yukari HatoNaoto KondoTatsuya Toyama Original Article 19 October 2015 Pages: 539 - 547
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer Antonia WennersFelix HartmannMaret Bauer Original Article 14 November 2015 Pages: 548 - 556
Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701) Koki NakanishiDaisuke KobayashiYasuhiro Kodera Original Article 07 November 2015 Pages: 557 - 565
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer—biweekly versus standard triweekly XELOX (The ORION Study) Chu MatsudaMichitaka HondaHideyuki Mishima Original Article 16 October 2015 Pages: 566 - 572
Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers Takeo MinaguchiToyomi SatohHiroyuki Yoshikawa Original Article 16 October 2015 Pages: 573 - 579
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia Akiko KudohShinya SatoTasuku Harada Original Article 27 November 2015 Pages: 580 - 587
Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma Takehiro SejimaTetsuya YumiokaAtsushi Takenaka Original Article 08 October 2015 Pages: 588 - 594
Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer Riu HamadaJun NakashimaMasaaki Tachibana Original Article 19 November 2015 Pages: 595 - 600
Erratum to: Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer Riu HamadaJun NakashimaMasaaki Tachibana Erratum 08 January 2016 Pages: 601 - 601
Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma Mark A. KashtanThejus T. JayakrishnanKiran K. Turaga Original Article 08 December 2015 Pages: 602 - 608
Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases Yasuhiro HiranoNaoki NakamuraTetsuo Akimoto Original Article 27 November 2015 Pages: 609 - 614
Sarcopenia as a predictor of major hepatectomy complications: a little addition Umit CintosunBattal Altun Letter to the Editor 26 November 2015 Pages: 615 - 615